Palexia - Key Visual

Your Severe chronic low back pain patients need:
THE TREATMENT WITH THE LOWER SIDE EFFECTS

Palexia® PR offers...

  • 40% less constipation than oxycodone/ naloxone4
  • A favourable gastrointestinal tolerability profile4
Palexia - Key
Palexia - Key Visual - Tolerability

Incidence of constipation a4

Palexia® - Incidence of constipation - Graph
Zoom

PALEXIA ® PR - SIGNIFICANTLY LESS CONSTIPATION COMPARED TO OXYCODONE/ NALOXONE4


Palexia - Key Visual - Adverse events

Treatment-emergent
ADVERSE EVENTS – TITRATION PHASEb4

Palexia® - Treatment-emergent adverse events - Graph
Zoom

PALEXIA® PR - FAVOURABLE TOLERABILITY4


View footnotes

a Studied in low back pain with a neuropathic pain component. Incidence of constipation during the overall treatment period.

b Studied in low back pain with a neuropathic pain component. TEAEs reported for >5% of patients in the treatment group during the titration period (Safety Set).

ABBREVIATIONS
GI, gastrointestinal
PR, prolonged-release